Ticker Scorecard - AGEN Basics Company: Agenus Inc. IPO Date: February 4, 2000 Sector: Healthcare Industry: Biotech Market Cap: $82.64M Activated in VL: True Average Daily Range Avg Daily Range: $0.12 | 3.38% Avg Daily Range (30 D): $0.12 | 3.67% Avg Daily Range (90 D): $0.14 | 3.91% Institutional Daily Volume Avg Daily Volume: .08M Avg Daily Volume (30 D): .38M Avg Daily Volume (90 D): .42M Trade Size Avg Trade Size (Sh.): 16 Avg Trade Size (Sh.) (30 D): 118 Avg Trade Size (Sh.) (90 D): 112 Institutional Trades Total Inst.Trades: 1,261 Avg Inst. Trade: $1.67M Avg Inst. Trade (30 D): $.66M Avg Inst. Trade (90 D): $1.04M Avg Inst. Trade Volume: .03M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.76M Avg Closing Trade (30 D): $.66M Avg Closing Trade (90 D): $1.04M Avg Closing Volume: 35.46K     News Jan 23, 2025 @ 7:13 PM MiNK Therapeutics Targets Immune Reconstitution to... Source: N/A Nov 12, 2024 @ 5:15 PM Agenus (AGEN) Q3 2024 Earnings Call Transcript Source: The Motley Fool Nov 2, 2024 @ 11:45 AM DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages In... Source: Faruqi & Faruqi, Llp Oct 31, 2024 @ 9:45 AM Agenus Inc. Sued for Securities Law Violations - I... Source: Prnewswire Oct 30, 2024 @ 10:54 PM Agenus Inc. Investors: Please contact the Portnoy ... Source: N/A Financials   TTM Q3 2024 Q2 2024 Basic EPS $2.09 $-3.08 $-2.52 Diluted EPS $2.09 $-3.08 $-2.52 Revenue $ 160.43M $ 25.11M $ 23.51M Gross Profit $ 159.8M $ 24.97M $ 23.39M Net Income / Loss $ -234.05M $ -67.21M $ -54.8M Operating Income / Loss $ -98.78M $ -31.5M $ -30.19M Cost of Revenue $ .63M $ .15M $ .12M Net Cash Flow $ -61.41M $ -48.68M $ 40.67M PE Ratio 1.80     Splits Apr 12, 2024:   20:1 Oct 03, 2011:   6:1